Laurent Provins
1420, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025
Author Correction: Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.
Journal: Nature structural & molecular biology
Published: March 06, 2025
Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.
Journal: Nature structural & molecular biology
Published: November 14, 2023
Functional characterization of the antiepileptic drug candidate, padsevonil, on GABAA receptors.
Journal: Epilepsia
Published: January 15, 2020
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 10, 2019
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor.
Journal: The Journal of pharmacology and experimental therapeutics
Published: July 08, 2019
Novel Strategies To Activate the Dopamine D1 Receptor: Recent Advances in Orthosteric Agonism and Positive Allosteric Modulation.
Journal: Journal of medicinal chemistry
Published: December 12, 2018
Discovery and development of SV2A PET tracers: Potential for imaging synaptic density and clinical applications.
Journal: Drug discovery today. Technologies
Published: September 05, 2017
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
Journal: Nuclear medicine and biology
Published: November 13, 2015
Back-up strategies in drug discovery: what, how and when?
Journal: Drug discovery today
Published: April 15, 2014
Last Updated: 09/26/2026